当前位置： SCI文献检索 > JOURNAL OF CARDIAC FAILURE期刊下所有文献 > Prolonged electrical muscle stimulation exercise improves strength, peak VO2, and exercise capacity in patients with stable chronic heart failure.

Prolonged electrical muscle stimulation exercise improves strength, peak VO2, and exercise capacity in patients with stable chronic heart failure.

Abstract：

BACKGROUND:Exercise training can help patients with chronic heart failure but may be limited in its applicability due to age and other comorbidities. This investigation evaluated training responses to prolonged electrical muscle stimulation (EMS) in patients with stable chronic heart failure. METHODS AND RESULTS:In a crossover designed study, 10 patients (age 66 +/- 6.5 years, 9 male) were randomized to 8 weeks of training or habitual activity before crossing over to the other limb after a washout period of 2 weeks. Training consisted of electrical muscle stimulation of the major leg muscles for a minimum of 1 hour, 5 days a week. Peak oxygen consumption, 6-minute walking distance test, body mass index, and quadriceps muscle strength were the end points. At baseline the mean values for peak oxygen consumption (VO(2)), 6-minute walking distance, quadriceps strength, and body mass index were 19.5 +/- 3.5 mL x kg x min, 415.1 +/- 56.6m, 377.9 +/- 110.4N, and 27.9 +/- 3.1 kg/m(2), respectively. After training, peak VO(2) increased to 21.2 +/- 5.1 mL x kg x min (P < .05), walking distance increased to 454.9 +/- 54.5M (P < .005), quadriceps strength increased to 404.9 +/- 108.6N (P < .005), whereas we did not observe a significant effect on body mass index (P > .05). CONCLUSIONS:EMS can be used in sedentary adults with stable chronic heart failure to improve physical fitness and functional capacity. It may provide a viable alternative for patients unable to undertake more conventional forms of exercise.

journal_name

J Card Fail

journal_title

Journal of cardiac failure

authors

Banerjee P,Caulfield B,Crowe L,Clark AL

doi

10.1016/j.cardfail.2008.11.005

subject

Has Abstract

pub_date

2009-05-01 00:00:00

pages

319-26

issue

4

eissn

1071-9164

issn

1532-8414

pii

S1071-9164(08)01084-1

journal_volume

15

pub_type

杂志文章,随机对照试验

相关文献

JOURNAL OF CARDIAC FAILURE文献大全
  • Utility of BNP in differentiating constrictive pericarditis from restrictive cardiomyopathy in patients with renal insufficiency.

    abstract：BACKGROUND:Differentiating between constrictive pericarditis (CP) and restrictive cardiomyopathy (RCMP) is difficult because of similar clinical and hemodynamic presentation. Brain natriuretic peptide (BNP) has been reported a useful noninvasive biomarker to differentiate CP from RCMP; however, its utility in patients ...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2007.05.001

    authors： Reddy PR,Dieter RS,Das P,Steen LH,Lewis BE,Leya FS

    更新日期：2007-10-01 00:00:00

  • Fatigue, inflammation, and projected mortality in heart failure.

    abstract：BACKGROUND:Fatigue is a prominent and poorly understood symptom of heart failure with reduced ejection fraction (HFrEF). The purpose of this study was to determine whether fatigue correlated with immune biomarkers and prognosis. METHODS/RESULTS:In patients with HFrEF (N = 59) and healthy controls (N = 25), we prospect...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2012.07.003

    authors： Fink AM,Gonzalez RC,Lisowski T,Pini M,Fantuzzi G,Levy WC,Piano MR

    更新日期：2012-09-01 00:00:00

  • Simultaneous right atrioventricular pacing: a novel model to study atrial remodeling and fibrillation in the setting of heart failure.

    abstract：BACKGROUND:Atrial fibrillation (AF) is a common arrhythmia which contributes to morbidity and mortality in patients with heart failure (HF). Atrial remodeling is a key substrate for the development of AF in HF. However, experimental models that study AF in the setting of HF have important limitations. We evaluated a ne...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2007.10.021

    authors： Laurent G,Moe GW,Hu X,Pui-Sze So P,Ramadeen A,Leong-Poi H,Doumanovskaia L,Konig A,Trogadis J,Courtman D,Strauss BH,Dorian P

    更新日期：2008-04-01 00:00:00

  • Searching for evidence: Refractory questions in advanced heart failure.

    abstract：BACKGROUND:Despite ample data from randomized clinical trials (RCTs), the management of advanced heart failure (HF) varies greatly. We examined the most common refractory questions arising in routine inpatient management of advanced HF. METHODS:From the inpatient HF service at 1 hospital, we prospectively recorded cli...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2003.10.006

    authors： Shah MR,Stevenson LW

    更新日期：2004-06-01 00:00:00

  • Hemodynamic changes and neurohumoral regulation during development of congestive heart failure in a model of epinephrine-induced cardiomyopathy in conscious rabbits.

    abstract：BACKGROUND:The present study was designed to study the progression of heart failure in rabbits with catecholamine-induced cardiomyopathy. METHODS AND RESULTS:We investigated the effects of three repetitive applications (at 16-day intervals) of high-dose epinephrine (first infusion, 5 micrograms/kg/min for 60 minutes; ...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/s1071-9164(99)90033-7

    authors： Muders F,Friedrich E,Luchner A,Pfeifer M,Ickenstein G,Hamelbeck B,Riegger GA,Elsner D

    更新日期：1999-06-01 00:00:00

  • Activities and Compensation of Advanced Heart Failure Specialists: Results of the Heart Failure Society of America (HFSA) Survey.

    abstract：BACKGROUND:In the current era, where advanced heart failure (AHF) has become an American Board of Internal Medicine-certified subspecialty, new data are needed to benchmark and value levels of clinical effort performed by AHF specialists (AHFMDs). METHODS AND RESULTS:A 36-question survey was sent to 728 AHFMDs, member...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2015.08.340

    authors： Klein L,Greenberg BH,Konstam MA,Gregory D,Kociol RD,Johnson MR,de Marco T

    更新日期：2015-11-01 00:00:00

  • Variability in the clinical status of patients with advanced heart failure.

    abstract：BACKGROUND:The importance of repeated clinical assessments of patients with heart failure is widely accepted. The frequency of such follow-up is not established and is likely to depend on the natural history and variability of patients' health status and the availability and use of appropriate treatments. METHODS AND ...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章,多中心研究

    doi：10.1016/j.cardfail.2003.12.008

    authors： Hauptman PJ,Masoudi FA,Weintraub WS,Pina I,Jones PG,Spertus JA,Cardiovascular Outcomes Research Consortium.

    更新日期：2004-10-01 00:00:00

  • Brief Report: Patient Activation Among Urban Hospitalized Patients With Heart Failure.

    abstract：BACKGROUND:Patient activation influences patients' ability to meaningfully engage in critical heart failure self-care. The purpose of this study was to identify whether patient activation is associated with patient-reported health outcomes in an urban and racially diverse inpatient sample of patients with heart failure...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2017.08.452

    authors： Masterson Creber R,Chen T,Wei C,Lee CS

    更新日期：2017-11-01 00:00:00

  • Regional variations in physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators.

    abstract：INTRODUCTION:This study was designed to determine if physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators (ICDs) are regionally associated with ICD use. METHODS AND RESULTS:A national sample of 9969 members of the American College of Cardiology was surveyed electronically. Resp...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2010.11.009

    authors： Matlock DD,Kutner JS,Emsermann CB,Al-Khatib SM,Sanders GD,Dickinson LM,Rumsfeld JS,Davidson AJ,Crane LA,Masoudi FA

    更新日期：2011-04-01 00:00:00

  • Pulmonary hypertension and systemic hypotension as limitations to exercise in chronic heart failure.

    abstract：:The authors have previously shown that the resistance ratio (RR) is increased in patients with congestive heart failure (CHF), and that the patients with the highest RRs have an increased mortality. The authors hypothesized that CHF patients with the lowest maximum oxygen consumption and the most impaired Weber functi...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/1071-9164(94)90005-1

    authors： Mabee SW,Metra M,Reed DE,Dei Cas L,Cody RJ

    更新日期：1994-10-01 00:00:00

  • Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy.

    abstract：BACKGROUND:The gene for cardiac troponin T (TNNT2) is 1 of 7 autosomal disease genes implicated in familial dilated cardiomyopathy (FDC). Identical deletions in exon 13 of TNNT2 have been reported in 2 families with FDC, but little is known about the frequency of this deletion among patients with FDC and idiopathic dil...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1054/jcaf.2002.31157

    authors： Hanson EL,Jakobs PM,Keegan H,Coates K,Bousman S,Dienel NH,Litt M,Hershberger RE

    更新日期：2002-02-01 00:00:00

  • Soluble Receptor for advanced glycation end products (RAGE) is a prognostic factor for heart failure.

    abstract：BACKGROUND:We recently reported that serum levels of pentosidine, one of the well-defined advanced glycation end products (AGE), was an independent prognostic factor for heart failure. Receptor for AGEs (RAGE) is expressed in a variety of tissues, and RAGE has a C-truncated secretory isoform of the receptor protein, te...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2007.10.019

    authors： Koyama Y,Takeishi Y,Niizeki T,Suzuki S,Kitahara T,Sasaki T,Kubota I

    更新日期：2008-03-01 00:00:00

  • Elevated Heart Rate Following Heart Transplantation Is Associated With Increased Graft Vasculopathy and Mortality.

    abstract：BACKGROUND:The effect of elevated heart rate (HR) on outcomes after heart transplantation (HT) has not been well established. The aim of this study was to assess predictors of elevated HR following HT and its impact on outcomes. METHODS AND RESULTS:We retrospectively evaluated 394 patients who underwent HT at 2 academ...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章,多中心研究

    doi：10.1016/j.cardfail.2019.01.009

    authors： Liebo M,Newman J,Joshi A,Lowes BD,Peled-Potashnik Y,Basha HI,Zolty R,Um JY,McGee E Jr,Heroux A,Raichlin E

    更新日期：2019-04-01 00:00:00

  • Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction.

    abstract：:The aim of this study was to compare the effects on left ventricular function and exercise tolerance of a selective beta-antagonist (atenolol) with those of another selective beta 1-antagonist with vasodilator properties (nebivolol) in patients with ischemic left ventricular dysfunction but no overt congestive heart f...

    journal_title：Journal of cardiac failure

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/s1071-9164(96)80004-2

    authors： Rousseau MF,Chapelle F,Van Eyll C,Stoleru L,Hager D,Van Nueten L,Pouleur H

    更新日期：1996-03-01 00:00:00

  • Racial differences in treatment-seeking delays among heart failure patients.

    abstract：BACKGROUND:Treatment-seeking delays for heart failure (HF) symptoms are significantly high. However, earlier studies did not closely examine race as a characteristic that could potentially influence delay times. The purpose of this study was (1) to describe racial differences in treatment-seeking delays for HF symptoms...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1054/jcaf.2002.129234

    authors： Evangelista LS,Dracup K,Doering LV

    更新日期：2002-12-01 00:00:00

  • Acute heart failure with and without concomitant acute coronary syndromes: patient characteristics, management, and survival.

    abstract：BACKGROUND:Acute coronary syndromes (ACS) may precipitate up to a third of acute heart failure (AHF) cases. We assessed the characteristics, initial management, and survival of AHF patients with (ACS-AHF) and without (nACS-AHF) concomitant ACS. METHODS AND RESULTS:Data from 620 AHF patients were analyzed in a prospect...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章,多中心研究

    doi：10.1016/j.cardfail.2014.07.008

    authors： Tarvasmäki T,Harjola VP,Nieminen MS,Siirilä-Waris K,Tolonen J,Tolppanen H,Lassus J,FINN-AKVA Study Group.

    更新日期：2014-10-01 00:00:00

  • Pioglitazone and heart failure: results from a controlled study in patients with type 2 diabetes mellitus and systolic dysfunction.

    abstract：BACKGROUND:Thiazolidinediones are associated with fluid retention, often interpreted as worsening cardiac function, limiting their use in patients with heart failure (HF). We compared the effects of pioglitazone and glyburide on cardiac function in patients with type 2 diabetes, systolic dysfunction, and New York Heart...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1016/j.cardfail.2008.02.007

    authors： Giles TD,Miller AB,Elkayam U,Bhattacharya M,Perez A

    更新日期：2008-08-01 00:00:00

  • Prognosis of Low Normal Left Ventricular Ejection Fraction in an Asymptomatic Population-Based Adult Cohort: The Multiethnic Study of Atherosclerosis.

    abstract：BACKGROUND:Reduced left ventricular systolic function predicts worse outcomes. However, the optimal threshold for "normal" left ventricular ejection fraction (LVEF) is uncertain. In general, LVEF ≥ 55% is considered to be "normal" by guidelines, with a low normal designation for LVEF being 50%-55%. We assessed the prog...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2016.03.013

    authors： Yeboah J,Rodriguez CJ,Qureshi W,Liu S,Carr JJ,Lima JA,Hundley WG,Herrington DM

    更新日期：2016-10-01 00:00:00

  • Clinical predictors and hemodynamic consequences of elevated peripheral chemosensitivity in optimally treated men with chronic systolic heart failure.

    abstract：AIMS:Augmented peripheral chemoreflex response is an important mechanism in the pathophysiology of chronic heart failure (CHF). This study characterizes prevalence and clinical predictors of this phenomenon in optimally managed male CHF patients, and seeks to describe the hemodynamic consequences of chemoreceptor hyper...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2013.03.013

    authors： Niewinski P,Engelman ZJ,Fudim M,Tubek S,Paleczny B,Jankowska EA,Banasiak W,Sobotka PA,Ponikowski P

    更新日期：2013-06-01 00:00:00

  • Extending the boundaries of cardiac resynchronization therapy: efficacy in atrial fibrillation, New York heart association class II, and narrow QRS heart failure patients.

    abstract：BACKGROUND:Large-scale clinical trials have demonstrated the benefits of cardiac resynchronization therapy (CRT) in patients with New York Heart Association (NYHA) Class III/IV heart failure, systolic left ventricular dysfunction, and a wide QRS. However, additional patient groups may also benefit from CRT. METHODS AN...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章,meta分析

    doi：10.1016/j.cardfail.2009.12.018

    authors： Wein S,Voskoboinik A,Wein L,Billah B,Krum H

    更新日期：2010-05-01 00:00:00

  • Serum pregnancy-associated plasma protein a in patients with heart failure.

    abstract：BACKGROUND:Pregnancy-associated plasma protein A (PAPP-A) proteolyzes insulin-like growth factor (IGF)-binding proteins and thus increases IGF-1 bioactivity. PAPP-A has been reported to be involved in various pathophysiologic abnormalities; however, the clinical significance of PAPP-A has not been examined in cases of ...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2011.05.011

    authors： Funayama A,Shishido T,Netsu S,Ishino M,Sasaki T,Katoh S,Takahashi H,Arimoto T,Miyamoto T,Nitobe J,Watanabe T,Kubota I

    更新日期：2011-10-01 00:00:00

  • Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.

    abstract：BACKGROUND:Genetic heterogeneity at the endothelial nitric oxide synthase (NOS3) locus influences heart failure outcomes. The prevalence of NOS3 variants differs in black and white cohorts, but the impact of these differences is unknown. METHODS AND RESULTS:Subjects (n = 352) in the Genetic Risk Assessment of Heart Fa...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.cardfail.2008.10.028

    authors： McNamara DM,Tam SW,Sabolinski ML,Tobelmann P,Janosko K,Venkitachalam L,Ofili E,Yancy C,Feldman AM,Ghali JK,Taylor AL,Cohn JN,Worcel M

    更新日期：2009-04-01 00:00:00

  • Decoupling Between Diastolic Pulmonary Arterial Pressure and Pulmonary Arterial Wedge Pressure at Incremental Left Ventricular Assist Device (LVAD) Speeds Is Associated With Worse Prognosis After LVAD Implantation.

    abstract：BACKGROUND:Decoupling between diastolic pulmonary arterial pressure (dPAP) and pulmonary arterial wedge pressure (PAWP) is an index of pulmonary vasculature remodeling and provides prognostic information. Furthermore, decoupling may change during incremental left ventricular assist device (LVAD) speed changes. METHODS...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2018.08.003

    authors： Imamura T,Kim G,Raikhelkar J,Sarswat N,Kalantari S,Smith B,Rodgers D,Chung B,Nguyen A,Ota T,Song T,Juricek C,Jeevanandam V,Burkhoff D,Sayer G,Uriel N

    更新日期：2018-09-01 00:00:00

  • HFSA 2006 Comprehensive Heart Failure Practice Guideline.

    abstract：:Heart failure (HF) is a syndrome characterized by high mortality, frequent hospitalization, reduced quality of life, and a complex therapeutic regimen. Knowledge about HF is accumulating so rapidly that individual clinicians may be unable to readily and adequately synthesize new information into effective strategies o...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章,实务指引

    doi：10.1016/j.cardfail.2005.11.005

    authors： Heart Failure Society Of America

    更新日期：2006-02-01 00:00:00

  • Improvement of serum NT-ProBNP predicts improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure.

    abstract：BACKGROUND:Cardiac resynchronization therapy (CRT) is now an established therapy for patients with advanced heart failure with electromechanical delay, although nonresponders have been observed. Because natriuretic peptides are relevant markers to reflect the severity of heart failure and filling pressure of cardiac ch...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2005.04.007

    authors： Yu CM,Fung JW,Zhang Q,Chan CK,Chan I,Chan YS,Kong SL,Sanderson JE,Lam CW

    更新日期：2005-06-01 00:00:00

  • A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling.

    abstract：BACKGROUND:Left ventricular remodeling after myocardial infarction is a key component of heart failure and it has long been postulated that it may result from increased wall stress. It has recently been suggested that an injectable, non-degradable polymer may limit pathological remodeling in a manner analogous to that ...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2009.03.003

    authors： Dobner S,Bezuidenhout D,Govender P,Zilla P,Davies N

    更新日期：2009-09-01 00:00:00

  • Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic.

    abstract：BACKGROUND:Drug-related negative outcomes (DNOs) are health problems that patients experience due to drug use or nonuse. Heart failure (HF) patients are at high risk of experiencing DNOs owing to polypharmacy, comorbidities, and age. METHODS AND RESULTS:Ninety-seven consecutive HF patients were enrolled and followed f...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2010.10.009

    authors： Gastelurrutia P,Benrimoj SI,Espejo J,Tuneu L,Mangues MA,Bayes-Genis A

    更新日期：2011-03-01 00:00:00

  • Predictors of myocardial dysfunction in human immunodeficiency virus-infected patients.

    abstract：BACKGROUND:Some of the most frequent manifestations of heart involvement in human immunodeficiency virus (HIV) infection include right and left ventricular dysfunction. The pathogenesis remains obscure. METHODS AND RESULTS:This prospective clinical and echocardiographic study involved 181 patients at all stages of HIV...

    journal_title：Journal of cardiac failure

    pub_type： 临床试验,杂志文章

    doi：10.1016/s1071-9164(98)90504-8

    authors： Silva-Cardoso J,Moura B,Ferreira A,Martins L,Bravo-Faria D,Mota-Miranda A,Rocha-Gonçalves F,Lecour H,Cerqueira-Gomes M

    更新日期：1998-03-01 00:00:00

  • Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats.

    abstract：BACKGROUND:Activated vitamin D analog, paricalcitol, has been shown to attenuate the development of cardiac hypertrophy in Dahl salt sensitive (DSS) rats. To determine whether an antihypertrophic effect is class specific, we tested if doxercalciferol (a pro-hormone vitamin D2 analog) could also attenuate the developmen...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2011.08.006

    authors： Choi JH,Ke Q,Bae S,Lee JY,Kim YJ,Kim UK,Arbeeny C,Thadhani R,Kang PM

    更新日期：2011-12-01 00:00:00

  • Association of functional and health status measures in heart failure.

    abstract：BACKGROUND:A wide variety of instruments have been used to assess the functional capabilities and health status of patients with chronic heart failure (HF), but it is not known how well these tests are correlated with one another, nor which one has the best association with measured exercise capacity. METHODS AND RESU...

    journal_title：Journal of cardiac failure

    pub_type： 杂志文章

    doi：10.1016/j.cardfail.2006.04.004

    authors： Myers J,Zaheer N,Quaglietti S,Madhavan R,Froelicher V,Heidenreich P

    更新日期：2006-08-01 00:00:00